Dudediligence.

Edwards Lifesciences Corporation

EWNYSE · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$1.35BSep ’24$1.39BDec ’24$1.41BMar ’25$1.53BJun ’25$1.55BSep ’25$1.57BDec ’25$1.65BMar ’26$1.74BJun ’26
Net income, by quarter
$3.07BSep ’24$385.6MDec ’24$358.0MMar ’25$333.2MJun ’25$291.1MSep ’25$91.2MDec ’25$380.7MMar ’26$241.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$5.23B$4.46B$5.01B$5.44B$6.07B
Gross profit$3.98B$3.74B$4.03B$4.32B$4.73B
Operating income$1.69B$1.50B$1.31B$1.38B$1.26B
Net income$1.50B$1.52B$1.40B$4.17B$1.07B
Operating cash flow$1.73B$1.22B$895.8M$542.3M$1.60B
Free cash flow$1.41B$973.6M$642.8M$289.9M$1.33B
Cash$862.8M$769.0M$1.13B$3.05B$2.94B
Debt$595.7M$596.3M$597.0M$597.7M$598.3M
Shares outstanding624.1M608.3M601.1M588.6M580.7M